Fred Alger Management, LLC Abb Vie Inc. Transaction History

Fred Alger Management, LLC

$19.7 Billion
Q1 2024

A detailed history of Fred Alger Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 115,095 shares of ABBV stock, worth $19.7 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares

115,095

Previous 63,688 80.72%

Holding current value

$19.7 Million

Previous $9.87 Million 112.36%

% of portfolio

0.11%

Previous 0.05%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $8.22 Million - $9.36 Million	51,407 Added 80.72%	115,095 $21 Million
Q4 2023 Feb 14, 2024	SELL	$137.6 - $154.97 $4.79 Million - $5.4 Million	-34,845 Reduced 35.36%	63,688 $9.87 Million
Q3 2023 Nov 14, 2023	SELL	$133.59 - $154.65 $11.3 Million - $13.1 Million	-84,443 Reduced 46.15%	98,533 $14.7 Million
Q2 2023 Aug 14, 2023	SELL	$132.51 - $164.9 $101 Million - $126 Million	-765,484 Reduced 80.71%	182,976 $24.7 Million
Q1 2023 May 15, 2023	SELL	$144.61 - $166.54 $105 Million - $121 Million	-727,003 Reduced 43.39%	948,460 $151 Million

Q4 2022 Feb 14, 2023	BUY	$138.31 - $165.87 $22.9 Million - $27.4 Million	165,489 Added 10.96%	1,675,463 $271 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $30.9 Million - $35.4 Million	229,925 Added 17.96%	1,509,974 $203 Million
Q2 2022 Aug 15, 2022	SELL	$137.62 - $174.96 $38.1 Million - $48.5 Million	-276,992 Reduced 17.79%	1,280,049 $196 Million
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $31.7 Million - $39.4 Million	-240,564 Reduced 13.38%	1,557,041 $252 Million
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $190 Million - $240 Million	1,766,693 Added 5715.23%	1,797,605 $243 Million
Q3 2021 Nov 15, 2021	SELL	$106.4 - $120.78 $9.49 Million - $10.8 Million	-89,167 Reduced 74.26%	30,912 $3.33 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $18 Million - $20.1 Million	-171,432 Reduced 58.81%	120,079 $13.5 Million
Q1 2021 May 17, 2021	SELL	$102.3 - $112.62 $47.1 Million - $51.9 Million	-460,589 Reduced 61.24%	291,511 $31.5 Million
Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $53.9 Million - $72.8 Million	669,584 Added 811.46%	752,100 $80.6 Million
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $7.49 Million - $8.79 Million	-87,212 Reduced 51.38%	82,516 $7.23 Million
Q2 2020 Aug 14, 2020	SELL	$73.37 - $98.18 $25.5 Million - $34.1 Million	-347,056 Reduced 67.16%	169,728 $16.7 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $42.5 Million - $64.5 Million	-659,485 Reduced 56.07%	516,784 $39.4 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $37.2 Million - $46.5 Million	515,272 Added 77.95%	1,176,269 $104 Million
Q3 2019 Nov 14, 2019	BUY	$62.98 - $75.72 $38.5 Million - $46.3 Million	611,751 Added 1242.23%	660,997 $50.1 Million
Q2 2019 Aug 14, 2019	BUY	$65.7 - $83.98 $2.28 Million - $2.91 Million	34,644 Added 237.26%	49,246 $3.58 Million
Q1 2019 May 14, 2019	SELL	$77.14 - $90.79 $351,372 - $413,548	-4,555 Reduced 23.78%	14,602 $1.18 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $303,805 - $337,736	-3,417 Reduced 15.14%	19,157 $1.81 Million
Q2 2018 Jul 19, 2018	SELL	$89.78 - $106.23 $166 Million - $196 Million	-1,845,687 Reduced 98.79%	22,574 $2.09 Million
Q1 2018 May 10, 2018	BUY	$92.01 - $123.21 $56.9 Million - $76.2 Million	618,563 Added 49.5%	1,868,261 $177 Million
Q4 2017 Feb 14, 2018	BUY	$89.56 - $98.21 $99.2 Million - $109 Million	1,108,061 Added 782.32%	1,249,698 $121 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $9.89 Million - $12.6 Million	141,637	141,637 $12.6 Million

Others Institutions Holding ABBV

# of Institutions

3,651

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.

Account

Fred Alger Management, LLC Abb Vie Inc. Transaction History